REPORT FROM THE 2009 AAN ANNUAL MEETING – High-dose vitamin D3 supplementation appears to be well tolerated and significantly reduces T cell reactivity, according to the results of a prospective Canadian trial (Burton et al. AAN 2009; abstract P01.110).
Read More
REPORT FROM THE 2009 AAN ANNUAL MEETING – Two studies have investigated the potential benefits of rituximab, a monoclonal antibody that targets CD20 B cells, in primary- and secondary-progressive MS (PPMS, SPMS).
Read More
REPORT FROM THE 2009 AAN ANNUAL MEETING – A pooled analysis (n=2,177) of six randomized double-blind trials of donepezil in Alzheimers disease has found that treatment is associated with a reduced decline in activities of daily living (ADL) (Gauthier et al. AAN 2009; abstract P06.079).
Read More
REPORT FROM THE 2009 AAN ANNUAL MEETING – A new multicentre study has found an increasing risk of Parkinsons disease with cumulative exposure to lead (Weisskopf et al. AAN 2009; abstract S23.001).
Read More
REPORT FROM THE 2009 AAN ANNUAL MEETING – An internet survey has been used to estimate the global prevalence of chronic migraine, defined as >15 headache days per month and a clinical diagnosis of migraine (Varon et al. AAN 2009; abstract P06.001).
Read More